Iproteos
Biotechnology company determined to improve human health by creating therapeutics for unmet medical needs in the central nervous system space.
Launch date
Employees
Market cap
-
Enterprise valuation
€6—9m (Dealroom.co estimates Oct 2016.)
Barcelona Catalonia (HQ)
- hard tech
- biotechnology
- horizon europe
- woman founder
- biotech and pharma
- spinout
- eit ecosystem
- neurology
- eit health
- drug development
- innovation management
- eit supernovas
- chemistry
- european health catapult (eit health)
- investor network (eit health)
- investor network 2018 (eit health)
- european health catapult 2019 (eit health)
- epilepsy
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m |
| % growth | - | (65 %) | 262 % | (90 %) | (60 %) |
| EBITDA | <1m | (<1m) | (<1m) | (<1m) | (<1m) |
| % EBITDA margin | 66 % | (415 %) | (51 %) | (682 %) | (3229 %) |
| Profit | (<1m) | (<1m) | (<1m) | (<1m) | (1.2m) |
| % profit margin | (32 %) | (645 %) | (136 %) | (2412 %) | (13064 %) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
* | €1.5m | Seed | |
N/A | Grant | ||
N/A | Grant | ||
N/A | Acquisition | ||
| Total Funding | €1.5m | ||
Related Content
Recent News about Iproteos
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.